Ackerman, Stacey J.; Sullivan, Erin M.; Beusterien, … - In: PharmacoEconomics 15 (1999) 2, pp. 179-195
Objective: Amyotrophic lateral sclerosis (ALS) is a fatal, degenerative neuromuscular disease characterised by a progressive loss of voluntary motor activity. Recombinant human insulin-like growth factor I (rhIGF-I) has been shown to be useful in treating ALS. The purpose of this study was to...